Over 107.7 mn Covid-19 vaccine doses available with States, UTs: Centre

Over 10.77 crore balance and unutilized Covid-19 vaccine doses are still available with the States and UTs to be administered, informed the Ministry of Health and Family Welfare on Thursday

Covid vaccine
ANI General News
2 min read Last Updated : Jul 07 2022 | 1:26 PM IST

Over 10.77 crore balance and unutilized COVID-19 vaccine doses are still available with the States and UTs to be administered, informed the Ministry of Health and Family Welfare on Thursday.

More than 193.53 crore (1,93,53,58,865) vaccine doses have been provided to States and UTs so far through Govt. of India (free of cost channel) and through the direct state procurement category.

Over 10.77 crore (10,77,58,570) balance and unutilized COVID vaccine doses are still available with the States and UTs to be administered.

The Union Government is committed to accelerating the pace and expanding the scope of COVID-19 vaccination throughout the country.

The nationwide COVID 19 vaccination started on January 16, 2021.

The new phase of universalization of COVID-19 vaccination commenced on June 21, 2021. The vaccination drive has been ramped up through the availability of more vaccines, advanced visibility of vaccine availability to States and UTs for enabling better planning by them and streamlining the vaccine supply chain.

As part of the nationwide vaccination drive, the Central government has been supporting the States and UTs by providing them with COVID vaccines free of cost.

In the new phase of the universalization of the COVID-19 vaccination drive, the Union Government will procure and supply (free of cost) 75 per cent of the vaccines being produced by the vaccine manufacturers in the country to States and UTs.

Meanwhile, India logged 18,930 fresh infections in the last 24 hours, an increase of 2,771 infections than yesterday, informed the Union Ministry of Health and Family Welfare on Thursday.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Subscribe to Business Standard digital and get complimentary access to The New York Times

Quarterly Starter

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

Save 46%

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories Online

  • Over 30 behind the paywall stories daily, handpicked by our editors for subscribers

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Coronavirus VaccineHealth MinistryVaccine

First Published: Jul 07 2022 | 1:26 PM IST

Next Story